Biomedical 3D-Printing Company Signs Agreement with Xilloc for Licensing, Sale of 3D-Printed Bones in Europe (3Ders.org) � NEXT 21 K.K., an innovative Japanese biomedical 3D-printing company, has created a 3D bone printer capable of producing artificial bone structures for humans. NEXT 21 K.K. has announced a deal with Dutch medical company Xilloc. Under the agreement, NEXT 21 provides Xilloc with a license to 3D-print and sell these customized bone structures in the European market.NEXT21 will also provide Xilloc CT with all the information needed for the registration, manufacturing, and selling of these �CT bones.� Before these 3D-printed bones actually hit the shelves, Xilloc needs to go through registration for on an EU-level on 93/42/EEC (Medical Device Directive MDD). After completing that registration, Xilloc will be able to begin manufacturing and selling these 3D-printed CT bones within Europe.